299 related articles for article (PubMed ID: 26826598)
1. Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction.
Sharma A; Kiripolsky J; Klimatcheva E; Howell A; Fereidouni F; Levenson R; Rothstein TL; Kramer JM
Clin Immunol; 2016 Mar; 164():85-94. PubMed ID: 26826598
[TBL] [Abstract][Full Text] [Related]
2. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS
Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced 4-1BB activation prevents the development of Sjӧgren's syndrome-like sialadenitis in non-obese diabetic mice.
Zhou J; You BR; Yu Q
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165605. PubMed ID: 31740402
[TBL] [Abstract][Full Text] [Related]
4. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice.
Kurosawa M; Shikama Y; Furukawa M; Arakaki R; Ishimaru N; Matsushita K
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669065
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.
Zhou J; Kawai T; Yu Q
Lab Invest; 2017 Apr; 97(4):458-467. PubMed ID: 28067896
[TBL] [Abstract][Full Text] [Related]
6. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.
Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI
Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863
[TBL] [Abstract][Full Text] [Related]
7. CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis.
Kramer JM; Klimatcheva E; Rothstein TL
J Leukoc Biol; 2013 Nov; 94(5):1079-89. PubMed ID: 23904442
[TBL] [Abstract][Full Text] [Related]
8. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
9. TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice.
Vosters JL; Roescher N; Illei GG; Chiorini JA; Tak PP
Oral Dis; 2012 May; 18(4):365-74. PubMed ID: 22212434
[TBL] [Abstract][Full Text] [Related]
10. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice.
Thompson C; Jacobsen H; Pomeranz Krummel D; Nagai K; Cooke A
Autoimmunity; 2004 Dec; 37(8):549-54. PubMed ID: 15763917
[TBL] [Abstract][Full Text] [Related]
11. Total glucosides of paeony (TGP) alleviates Sjogren's syndrome through inhibiting inflammatory responses in mice.
Li B; Liu G; Liu R; He S; Li X; Huang L; Wang Z; Li Y; Chen Y; Yin H; Fang W
Phytomedicine; 2020 Jun; 71():153203. PubMed ID: 32402913
[TBL] [Abstract][Full Text] [Related]
12. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
[TBL] [Abstract][Full Text] [Related]
13. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
[TBL] [Abstract][Full Text] [Related]
14. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.
Groom J; Kalled SL; Cutler AH; Olson C; Woodcock SA; Schneider P; Tschopp J; Cachero TG; Batten M; Wheway J; Mauri D; Cavill D; Gordon TP; Mackay CR; Mackay F
J Clin Invest; 2002 Jan; 109(1):59-68. PubMed ID: 11781351
[TBL] [Abstract][Full Text] [Related]
15. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
[TBL] [Abstract][Full Text] [Related]
16. [Biopsy of the minor salivary glands in the differential diagnosis of Sjögren's syndrome and chronic sialadenitis].
Afanas'ev VV; Vinogradov VI
Ter Arkh; 1988; 60(4):38-9. PubMed ID: 3394094
[TBL] [Abstract][Full Text] [Related]
17. Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.
Puñet-Ortiz J; Sáez Moya M; Cuenca M; Caleiras E; Lazaro A; Engel P
Front Immunol; 2018; 9():2661. PubMed ID: 30519241
[TBL] [Abstract][Full Text] [Related]
18. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
[TBL] [Abstract][Full Text] [Related]
19. Myd88 is required for disease development in a primary Sjögren's syndrome mouse model.
Kiripolsky J; McCabe LG; Gaile DP; Kramer JM
J Leukoc Biol; 2017 Dec; 102(6):1411-1420. PubMed ID: 28951424
[TBL] [Abstract][Full Text] [Related]
20. Interaction between innate immunity and Ro52-induced antibody causes Sjögren's syndrome-like disorder in mice.
Szczerba BM; Kaplonek P; Wolska N; Podsiadlowska A; Rybakowska PD; Dey P; Rasmussen A; Grundahl K; Hefner KS; Stone DU; Young S; Lewis DM; Radfar L; Scofield RH; Sivils KL; Bagavant H; Deshmukh US
Ann Rheum Dis; 2016 Mar; 75(3):617-22. PubMed ID: 25906316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
